Impact of an Interventional Program on Self-Management
ConditionDiabetes Self Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
The goal of this randomized clinical trial study is to assess the effect of an interventional program on diabetes self-management and therefore on effective glycemic control among diabetic students in Assuit university
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Diabetic students with severe disability or handicapped
Diabetic students known to have another health problem make him un tolerable to do exercise such as cardiovascular disease, bronchial asthma
Diabetic students with speech and hearing difficulties.
Trial design
Design model
Parallel
Treatments tested in this trial
educational program
Other interventioninterventional program consists of educational part and training part in case of agreement of participants
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: intervention groupExperimental treatment 1 intervention
Group B: control groupOther 1 intervention
Trial outcomes
Primary outcomes
1
assessment of change in Perceived Obstacles to diabetes self-management that faced by participants
by short version of the diabetic obstacle questionnaire.
Time frame
at base line, three months and six months after the end of the program.2
assessment of Change in Diabetes Self-management
by diabetes self-management questionnaire,
Time frame
at base line, three months and six months after the end of the program.3
assessment of change in measurements of glycated hemoglobin (HbA1c)
by blood analysis to measure (HbA1c)
Time frame
at base line, three months and six months after the end of the program.Secondary outcomes
1
assessment of change in measurement of body mass index (BMI)
by measurement of weight in kilograms and height in meters and use formula: (BMI) = weight in kilograms ÷ ( height in meter × height in meter)
Time frame
at base line, three months and six months after the end of the program.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov